Methylisothiazolinone allergic contact dermatitis: Assessment of relapses in 139 patients after avoidance advice

Pauline Bouschon (1) , Julie Waton (2) , Bruno Pereira (3) , Jean-Luc Schmutz (2) , Marie-Christine Le Bouëdec , Michel d'Incan (4, 5)

1 FM - UCA - Faculté de Médecine - Clermont-Auvergne
2 Service de Dermatologie et Allergologie [CHRU Nancy]
3 DRCI - Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand]
4 IMoST - Imagerie Moléculaire et Stratégies Théranostiques
5 Service de Dermatologie et Oncologie Cutanée [CHU Clermont-Ferrand]

Methylisothiazolinone (MI) is a preservative that is responsible for an epidemic of allergic contact dermatitis (ACD). Few studies have been published on the prognosis of patients with MI-induced ACD.

Mots clés: contact dermatitis; hand dermatitis; methylisothiazolinone; prognosis

Domaines: Cancer

Pauline Bouschon, Julie Waton, Bruno Pereira, Jean-Luc Schmutz, Marie-Christine Le Bouëdec, et al.. Methylisothiazolinone allergic contact dermatitis: Assessment of relapses in 139 patients after avoidance advice. Contact Dermatitis, 2019, 80 (5), pp.304-310. ⟨10.1111/cod.13221⟩. ⟨hal-02089810⟩